• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度浦那未感染艾滋病毒女性对PRO2000阴道凝胶的接受度。

Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India.

作者信息

Joglekar N, Joshi S, Kakde M, Fang G, Cianciola M, Reynolds S, Mehendale S

机构信息

National AIDS Research Institute, Indian Council of Medical Research (ICMR), India.

出版信息

AIDS Care. 2007 Jul;19(6):817-21. doi: 10.1080/09540120601133576.

DOI:10.1080/09540120601133576
PMID:17573603
Abstract

Acceptability of PRO2000 Gel, a candidate vaginal microbicide, among participants of its Phase I safety study in Pune, India is reported here. Forty-two eligible women were enrolled in a study requiring twice daily intra-vaginal product use for 14 consecutive days between menses. Acceptability was assessed at study exit through structured questionnaires among 41 participants who completed the product use, and five focus group discussions involving 31 study participants. The participants generally liked the product (40/41, 97.2%), especially its colour (40, 97.2%) and consistency (35, 85.3%). Thirty-four participants reported sexual intercourse within one hour of product use, at least once during the study period and sexual pleasure was reported to be better or unaffected among (30, 88.2%) participants. Nearly 70% did not like its smell and mentioned preference for a product that would be unnoticeable to the male partner. Participating women were concerned about privacy in usage and storage of the product. Acceptability of PRO2000 vaginal gel was good, but its smell will have to be improved. Counselling to address women's concerns about privacy and storage will be crucial. Women's preference for unnoticeable product indicates their empowerment and willingness to accept female-controlled options for HIV prevention.

摘要

本文报道了候选阴道杀菌剂PRO2000凝胶在印度浦那进行的I期安全性研究参与者中的可接受性。42名符合条件的女性参与了一项研究,该研究要求在两次月经期间连续14天每天两次阴道内使用该产品。在研究结束时,通过结构化问卷对41名完成产品使用的参与者进行了可接受性评估,并对31名研究参与者进行了五次焦点小组讨论。参与者总体上喜欢该产品(40/41,97.2%),尤其喜欢其颜色(40人,97.2%)和质地(35人,85.3%)。34名参与者报告在使用产品后一小时内发生性行为,在研究期间至少有一次,88.2%(30人)的参与者报告性快感更好或未受影响。近70%的人不喜欢它的气味,并表示更喜欢男性伴侣不易察觉的产品。参与研究的女性担心产品使用和储存过程中的隐私问题。PRO2000阴道凝胶的可接受性良好,但其气味有待改善。解决女性对隐私和储存问题的咨询至关重要。女性对不易察觉产品的偏好表明她们有自主权,并愿意接受女性主导的艾滋病毒预防方案。

相似文献

1
Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India.印度浦那未感染艾滋病毒女性对PRO2000阴道凝胶的接受度。
AIDS Care. 2007 Jul;19(6):817-21. doi: 10.1080/09540120601133576.
2
Acceptability of Praneem polyherbal vaginal tablet among HIV uninfected women & their male partners in Pune, India--Phase I study.印度浦那未感染艾滋病毒的女性及其男性伴侣对Praneem多草药阴道片的可接受性——I期研究。
Indian J Med Res. 2006 Apr;123(4):547-52.
3
Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India.可接受性和依从性:印度浦那一项候选阴道杀微生物剂“Praneem 多草药片”的 II 期研究结果。
Trans R Soc Trop Med Hyg. 2010 Jun;104(6):412-5. doi: 10.1016/j.trstmh.2009.12.007. Epub 2010 Jan 22.
4
Acceptability of Carraguard vaginal gel use among Thai couples.泰国夫妇对使用角叉菜胶阴道凝胶的接受度。
AIDS. 2006 Nov 14;20(17):2141-8. doi: 10.1097/QAD.0b013e32801086c9.
5
Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.硫酸纤维素作为HIV感染女性阴道杀菌剂的安全性和可接受性。
AIDS. 2006 May 12;20(8):1109-16. doi: 10.1097/01.aids.0000226950.72223.5f.
6
User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa.在南部非洲进行的一项艾滋病预防试验中,子宫帽和润滑剂凝胶的用户体验及可接受性特征。
AIDS Care. 2011 Aug;23(8):1026-34. doi: 10.1080/09540121.2010.543879.
7
Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050).在美国一项一期临床试验(HPTN 050)中,男性参与者对替诺福韦凝胶作为阴道杀菌剂的接受度。
AIDS Care. 2007 Sep;19(8):1026-31. doi: 10.1080/09540120701294237.
8
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women.替诺福韦阴道凝胶在禁欲及有性行为的HIV感染和未感染女性中的安全性和耐受性
AIDS. 2006 Feb 28;20(4):543-51. doi: 10.1097/01.aids.0000210608.70762.c3.
9
A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.一项随机、安慰剂对照试验,旨在评估泰国异性恋伴侣使用角叉菜胶阴道凝胶的安全性和可接受性。
Sex Transm Dis. 2008 Mar;35(3):226-32. doi: 10.1097/OLQ.0b013e31815d6e0d.
10
A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.一项在喀麦隆女性中进行的随机、双盲、安慰剂对照的两种隐形避孕套配方的安全性和可接受性研究。
Contraception. 2009 Nov;80(5):484-92. doi: 10.1016/j.contraception.2009.03.020. Epub 2009 May 23.

引用本文的文献

1
Design aspects of vaginal applicators that influence acceptance among target users.阴道给药器的设计方面会影响目标使用者的接受程度。
Sci Rep. 2021 May 7;11(1):9802. doi: 10.1038/s41598-021-89284-3.
2
Innovative sensory methods to access acceptability of mixed polymer semisoft ovules for microbicide applications.用于评估混合聚合物半软栓剂作为杀微生物剂应用时可接受性的创新感官方法。
Drug Deliv Transl Res. 2016 Oct;6(5):551-64. doi: 10.1007/s13346-016-0309-8.
3
Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India.
抗逆转录病毒暴露前预防:减缓印度艾滋病毒传播的新机遇。
Indian J Med Res. 2016 Feb;143(2):125-8. doi: 10.4103/0971-5916.180194.
4
Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design.可感知性与“选择体验”:用户的感官感知和体验为阴道预防产品设计提供信息。
AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1022-1030. doi: 10.1089/AID.2015.0275. Epub 2016 Mar 29.
5
Using a 2-stage strategy with respondent-driven sampling to recruit a hard-to-reach population for a placebo microbicide gel clinical trial in Nellore, Andhra Pradesh (India).在印度安得拉邦内洛尔进行的一项安慰剂杀微生物凝胶临床试验中,采用两阶段策略结合应答驱动抽样方法,以招募难以接触到的人群。
AIDS Behav. 2015 Feb;19(2):369-79. doi: 10.1007/s10461-014-0938-1.
6
Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.设计临床前可感知性测量方法以评估局部阴道凝胶制剂:将使用者的感官感知和体验与制剂特性相关联。
AIDS Res Hum Retroviruses. 2014 Jan;30(1):78-91. doi: 10.1089/AID.2013.0099. Epub 2013 Dec 9.
7
Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.巴布亚新几内亚的阴道内性行为及杀微生物剂可接受性:对中等流行率地区艾滋病毒预防工作的启示
BMC Res Notes. 2012 Nov 1;5:613. doi: 10.1186/1756-0500-5-613.
8
Moving beyond safe sex to women-controlled safe sex: a concept analysis.超越安全性行为,实现女性控制的安全性行为:概念分析。
J Adv Nurs. 2012 Aug;68(8):1858-69. doi: 10.1111/j.1365-2648.2011.05881.x. Epub 2011 Nov 23.
9
"Tell Juliana": acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study.“告诉朱莉安娜”:在参与 1 期杀微生物剂研究的不同种族、活跃的年轻女性中,候选杀微生物剂 VivaGel®和两种安慰剂凝胶的可接受性。
AIDS Behav. 2012 Oct;16(7):1761-74. doi: 10.1007/s10461-011-0028-6.
10
Feasibility of Repurposing the Polyanionic Microbicide, PPCM, for Prophylaxis against HIV Transmission during ART.重新利用聚阴离子杀微生物剂PPCM预防抗逆转录病毒治疗期间HIV传播的可行性。
ISRN Obstet Gynecol. 2011;2011:524365. doi: 10.5402/2011/524365. Epub 2010 Nov 28.